FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to a topical composition for treating a dermatological condition, selected from atopic dermatitis, seborrheic dermatitis, alopecia, contact dermatitis, psoriasis, urticaria, eczema, burns, sunburn, pancreatitis, hepatitis, Wilson's lichen, scleritis, scleroderma, dermatomyositis or a combination thereof, containing from 0.2% to 0.9% by weight of a composition for topical application of a compound of formula (I) , or a pharmaceutically acceptable salt thereof, two agents for preventing separation, containing 20–40% of polyethylene glycol, having an average molecular weight of 4,000 kDa, and 7.2–8.8% of glycerol monostearate by weight of the topical formulation, 40% to 60% by weight of the topical formulation PEG 400 as a solvent, from 4% to 6% by weight of a composition for topical application of white vaseline as a base, and 9–11% by weight of a composition for topical application of isopropyl myristate as an absorption enhancer, where pharmaceutically acceptable salt is selected from a group, consisting of hydrochloride, hydrobromide, sulphate, nitrate, phosphate, acetate, succinate, fumarate, maleate, tartrate, citrate, lactate, stearate, benzoate, methanesulphonate, ethanesulphonate, p-toluenesulphonate or benzenesulphonate.
EFFECT: there are presented compositions based on PDE-4 inhibitors for local application and methods of their application.
13 cl, 8 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
QUINAZOLINE DERIVATIVES | 2007 |
|
RU2431632C2 |
COMPOSITION FOR TOPICAL USE | 1995 |
|
RU2181592C2 |
NON-REACTIONABLE HYDROPHILIC POLYMERS WITH TERMINAL SILOXANES AND FIELDS OF APPLICATION THEREOF | 2011 |
|
RU2565591C2 |
PHARMACEUTICAL COMPOSITION FOR HISTONE DEACETYLASE INHIBITORS | 2011 |
|
RU2625758C2 |
ADJUVANTS AND METHODS OF THEIR APPLICATION | 2008 |
|
RU2412595C1 |
BORINIC COMPOSITIONS | 2010 |
|
RU2521248C2 |
PHARMACEUTICAL COMPOSITION FOR LOCAL ADMINISTRATION | 2015 |
|
RU2703557C1 |
METHODS AND SYSTEMS FOR LEACHING SILICON HYDROGEL OPHTHALMIC LENSES | 2006 |
|
RU2399492C2 |
NEW PHARMACEUTICAL COMPOSITIONS | 1999 |
|
RU2240121C2 |
ORAL CARE COMPOSITIONS AND METHODS FOR USE THEREOF | 2017 |
|
RU2738847C1 |
Authors
Dates
2022-03-24—Published
2017-06-07—Filed